Product class:
|
Medicinal product with marketing authorization
|
Medicinal product class:
|
Human medicine
|
Name of medicinal product:
|
ADENURIC
|
Active substances:
|
|
ATC code:
|
M04AA03
|
Dosage form:
|
film-coated tablet
|
Strength:
|
80mg
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Summary of product characteristics (SPC):
|
|
Package information leaflet (PIL):
|
EST
|
Labelling:
|
|
Indication:
|
Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).
ADENURIC is indicated in adults.
|
Safety features:
|
Yes
|
Marketing authorization holder:
|
Menarini International Operations Luxembourg S.A.
|
Marketing authorization number:
|
EU/1/08/447
|
Marketing authorization issued on:
|
April 21, 2008
|
Marketing authorization expires on:
|
Unlimited
|
Marketing authorization procedure type:
|
Centralised
|
Assessment report:
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
1349287
|
ADENURIC
|
film-coated tablet
|
80mg 28TK
|
Prescription
|
50% 90% 100% 75%
|
7,84
|
21.03.2024
|
|
|
1349298
|
ADENURIC
|
film-coated tablet
|
80mg 84TK
|
Prescription
|
|
|
|
|
|
1492961
|
ADENURIC
|
film-coated tablet
|
80mg 14TK
|
Prescription
|
|
|
|
|
|
1492972
|
ADENURIC
|
film-coated tablet
|
80mg 42TK
|
Prescription
|
|
|
|
|
|
1492983
|
ADENURIC
|
film-coated tablet
|
80mg 56TK
|
Prescription
|
|
|
|
|
|
1492994
|
ADENURIC
|
film-coated tablet
|
80mg 98TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere